Table III.
Capecitabine (n=56) | FOLFIRI (n=67) | |||||
---|---|---|---|---|---|---|
|
|
|||||
n | % | n | % | χ2 | p-value | |
Overall responseb | 8 | 16.4 | 18 | 28.1 | 2.18 | 0.1398 |
Complete response | 2 | 4.1 | 6 | 9.4 | 0.51c | 0.4733c |
Partial response | 6 | 12.3 | 12 | 18.7 | 0.88 | 0.3491 |
Stable disease | 28 | 57.1 | 35 | 54.7 | 0.07 | 0.7945 |
Progressive disease | 13 | 26.5 | 12 | 17.2 | 1.45 | 0.2288 |
Not evaluable | 7 | 12.5 | 2 | 3.0 |
Based on the results by Stec et al (10).
Complete plus partial response.
Values calculated by the Chi-square (χ2) test with Yates correction.
FOLFIRI, 5-fluorouracil, leucovorin and irinotecan.